ASHLEY MAY: Open Payments
NPI 1073377305 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 60 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $928 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $495 |
| UCB, Inc. | 8 | $142 |
| Amgen Inc. | 7 | $130 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Genentech USA, Inc. | 4 | $84 |
| Radius Health, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $51 |
| Fresenius Kabi USA, LLC | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| PFIZER INC. | 2 | $38 |
Products named: RINVOQ, SKYRIZI, Bimzelx, KRYSTEXXA, ILARIS, Actemra, TALTZ, UPLIZNA.
Industry payments across DE — which companies pay providers there.
